Quick Answer
Biofrontera Inc. reported Total Assets of $28.56 million for the year ending 2025.
- Biofrontera Inc. showed an increase of +29.2% in Total Assets from 2024 to 2025.
- This data is from Biofrontera Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $15.35 million | Q1 2022: $49.20 million | Q2 2022: $53.63 million | Q3 2022: $55.06 million | Q1 2023: $41.97 million | Q2 2023: $36.91 million | Q3 2023: $34.10 million | Q1 2024: $24.58 million | Q2 2024: $21.57 million | Q3 2024: $18.52 million | Q1 2025: $16.59 million | Q2 2025: $20.14 million | Q3 2025: $15.42 million.
- Over the full 6 years of available data (2020 to 2025), Biofrontera Inc.'s Total Assets has grown by 18.3%.
- Historical annual values: Fiscal year 2025: $28.56 million | Fiscal year 2024: $22.10 million | Fiscal year 2023: $27.93 million | Fiscal year 2022: $50.88 million | Fiscal year 2021: $53.22 million | Fiscal year 2020: $24.14 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: